---
title: "Bank of America Securities Keeps Their Buy Rating on Vita Coco Company (COCO)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293771535.md"
description: "Bank of America Securities analyst Peter Galbo reiterated a Buy rating on Vita Coco Company (COCO) with an $85 price target. Piper Sandler also issued a Buy rating today, while William Blair maintained a Hold rating yesterday."
datetime: "2026-07-24T14:35:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293771535.md)
  - [en](https://longbridge.com/en/news/293771535.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293771535.md)
---

# Bank of America Securities Keeps Their Buy Rating on Vita Coco Company (COCO)

Bank of America Securities analyst Peter Galbo reiterated a Buy rating on Vita Coco Company today and set a price target of $85.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Galbo is a 3-star analyst with an average return of 2.4% and a 51.28% success rate. Galbo covers the Consumer Defensive sector, focusing on stocks such as Primo Brands, Coca-Cola, and Tyson Foods.

In addition to Bank of America Securities, Vita Coco Company also received a Buy from Piper Sandler’s Michael Lavery in a report issued today. However, yesterday, William Blair maintained a Hold rating on Vita Coco Company (NASDAQ: COCO).

### Related Stocks

- [COCO.US](https://longbridge.com/en/quote/COCO.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [KO.US](https://longbridge.com/en/quote/KO.US.md)
- [TSN.US](https://longbridge.com/en/quote/TSN.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Oppenheimer Asset Management Inc. Buys Shares of 29,022 Vita Coco Company, Inc. $COCO](https://longbridge.com/en/news/296083123.md)
- [Vita Coco (COCO) Earnings Call Signals Robust Growth](https://longbridge.com/en/news/294285807.md)
- [KBW Reaffirms Their Buy Rating on Kayne Anderson BDC, Inc. (KBDC)](https://longbridge.com/en/news/296081216.md)
- [Halozyme Buy Rating Reiterated as VYVGART Hytrulo Data Support Royalty Growth; $115 Price Target Unchanged](https://longbridge.com/en/news/296135927.md)
- [LifeSci Capital Reaffirms Their Buy Rating on Spyre Therapeutics (SYRE)](https://longbridge.com/en/news/296003421.md)